Active Ingredient History

  • Now
Acenocoumarol is mono-coumarin derivative with racemic mixture of R (+) and S (-) enantiomers. Acenocoumarol is structurally similar to vitamin K and is competitively able to inhibit the enzyme vitamin K-epoxide reductase. It exerts anticoagulant action by preventing the regeneration of reduced vitamin K by interfering with action of vitamin K epoxide reductase. Acenocoumarol is prescribed as the anticoagulant in various thromboembolic disorders.   NCATS

  • SMILES: CC(=O)CC(C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
  • Mol. Mass: 353.3255
  • ALogP: 3.52
  • ChEMBL Molecule:
More Chemistry
3-(alpha-(4'-nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin | 3-(alpha-acetonyl-4-nitrobenzyl)-4-hydroxycoumarin | 3-(alpha-acetonyl-p-nitrobenzyl)-4-hydroxycoumarin | 3-(alpha-(p-nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin | 3-(alpha-p-nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin | 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2h-1-benzopyran-2-one | 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2h-chromen-2-one | acenocoumarin | acenocoumarol | acenocoumarolum | acenocumarol | acenocumarolo | acenokumarin | g 23350 | g-23350 | nicoumalone | nicumalon | nitrophenylacetylethyl-4-hydroxycoumarine | nitrovarfarian | nitrowarfarin | sinthrome | sintrom


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue